| Original language | English (US) |
|---|---|
| Pages (from-to) | 1272-1275 |
| Number of pages | 4 |
| Journal | JACC: Cardiovascular Interventions |
| Volume | 13 |
| Issue number | 10 |
| DOIs | |
| State | Published - May 25 2020 |
Bibliographical note
Funding Information:Please note: The original work was supported by ACIST Medical Systems. Dr. Kobayashi has been a consultant for ACIST Medical Systems. Dr. Price has been a consultant for AstraZeneca, ACIST Medical, Boston Scientific, Medtronic, St. Jude Medical, and The Medicines Company; and receives speaker fees from AstraZeneca, Abbott Vascular, Medtronic, St. Jude Medical, Terumo, Chiesi USA, and The Medicines Company. Dr. Seto has received research support from ACIST Medical Systems; and has received speaking fees from ACIST Medical Systems and Volcano/Philips. Dr. Sarembock has been a consultant for Boston Scientific. Dr. Raveendran has been a consultant for Zurich Medical. Dr. Jeremias has been a consultant for Abbott Vascular, Philips/Volcano, ACIST Medical Systems, and Boston Scientific; and has served on the Speakers Bureau of Medtronic. Dr. Fearon has received research support from Abbott Vascular and Medtronic; has been a consultant for CathWorks and HeartFlow; and holds minor stock options with HeartFlow. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Funding Information:
Please note: The original work was supported by ACIST Medical Systems. Dr. Kobayashi has been a consultant for ACIST Medical Systems. Dr. Price has been a consultant for AstraZeneca, ACIST Medical, Boston Scientific, Medtronic, St. Jude Medical, and The Medicines Company; and receives speaker fees from AstraZeneca, Abbott Vascular, Medtronic, St. Jude Medical, Terumo, Chiesi USA, and The Medicines Company. Dr. Seto has received research support from ACIST Medical Systems; and has received speaking fees from ACIST Medical Systems and Volcano/Philips. Dr. Sarembock has been a consultant for Boston Scientific. Dr. Raveendran has been a consultant for Zurich Medical. Dr. Jeremias has been a consultant for Abbott Vascular, Philips/Volcano, ACIST Medical Systems, and Boston Scientific; and has served on the Speakers Bureau of Medtronic. Dr. Fearon has received research support from Abbott Vascular and Medtronic; has been a consultant for CathWorks and HeartFlow; and holds minor stock options with HeartFlow. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
